fulgent genetics stock news

10 stocks we like better than Fulgent Genetics, Inc. The stock of Fulgent Genetics (NASDAQ: FLGT), a genetic testing company, is up more than 300% this year. View Fulgent Genetics' earnings history. This suggests a possible upside of 23.9% from the stock's current price. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Only 31.05% of the stock of Fulgent Genetics is held by institutions. Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutio... Zacks Investment Research - 2 weeks ago Get daily stock ideas top-performing Wall Street analysts. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Fulgent Genetics against related stocks people have also bought. Shares of genetic testing specialist Fulgent Genetics (NASDAQ: FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. Learn more. To see all exchange delays and terms of use please see disclaimer. Please log in to your account or sign up in order to add this asset to your watchlist. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. On average, they anticipate Fulgent Genetics' stock price to reach $55.80 in the next year. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. View insider buying and selling activity for Fulgent Genetics or or view top insider-buying stocks. TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that it has updated its revenue guidance for the full year 2020 due to accelerating demand for its COVID-19 testing solutions. View real-time stock prices and stock quotes for a full financial overview. Fulgent Genetics employs 473 workers across the globe. Fulgent Genetics does not currently pay a dividend. Get the latest Fulgent Genetics Inc (FLGT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 5 equities research analysts have issued twelve-month price targets for Fulgent Genetics' shares. Get short term trading ideas from the MarketBeat Idea Engine. (Add your “underperform” vote.). The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.51. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Shares of FLGT can be purchased through any online brokerage account. FLGT stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Raymond James Trust N.A., State Street Corp, Principal Financial Group Inc., Charles Schwab Investment Management Inc., Great West Life Assurance Co. Can, Great West Life Assurance Co. Can, and Wells Fargo & Company MN. LANES, Fulgent Genetics and LA ... News 11/10/2020. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Shares of genetic testing specialist Fulgent Genetics (NASDAQ:FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. For … MarketBeat just released five new trading ideas, but Fulgent Genetics wasn't one of them. Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Why Fulgent Genetics Stock Is Soaring 11.2% Today The Motley Fool 11/13/2020. According to analysts' consensus price target of $55.80, Fulgent Genetics has a forecasted upside of 23.8% from its current price of $45.09. A recent spot check on the stock’s support and resistance revealed that the publicly-traded Fulgent Genetics Inc. (NASDAQ: FLGT) shares are trading at a price close to -12.67% lower than its 90-day high. Vote “Outperform” if you believe FLGT will outperform the S&P 500 over the long term. Do Not Sell My Information. Yahoo | December 10, 2020 Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Square (SQ), JD.com (JD), Marvell Technology Group (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT). Fulgent Genetics has a market capitalization of $1.09 billion and generates $32.53 million in revenue each year. The company issued 4,600,000 shares at $12.00-$14.00 per share. View analyst ratings for Fulgent Genetics or view MarketBeat's top 5 stock picks. View our earnings forecast for Fulgent Genetics. FLGT has a greater number of analysts covering the stock than 34.62% of Healthcare stocks. Learn more. If you invested a modest $1,000 into shares of Fulgent Genetics (NASDAQ:FLGT) back in January, that investment would have turned into $3,750 as of Dec. 8. Company insiders that own Fulgent Genetics stock include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim. All rights reserved. On the other hand, the stock is +63.89% away from its low in the 90-day period. Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT.". You may vote once every thirty days. Fulgent Genetics Inc's upside potential (average analyst target price relative to current price) is higher than 74.71% of all US stocks. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Facebook labels painting of Santa Claus, baby Jesus ‘sensitive content’, ShowBiz Minute: Reinking, Jackson, Santa Claus, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Fulgent Genetics has received a consensus rating of Hold. Fulgent Genetics had a net margin of 35.31% and a return on equity of 43.81%. FLGT, Fulgent Genetics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. A high-level overview of Fulgent Genetics, Inc. (FLGT) stock. Fundamental company data provided by Morningstar and Zacks Investment Research. Since then, FLGT stock has increased by 347.6% and is now trading at $45.03. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Get the latest news and breaking stories for Fulgent Genetics (FLGT) stock. The company can be reached via phone at 626-350-0537 or via email at [email protected]. Specifically, they have bought $0.00 in company stock and sold $7,125,530.00 in company stock. Get the latest Fulgent Genetics, Inc. (FLGT) stock news and headlines to help you in your trading and investing decisions. View insider buying and selling activity for Fulgent Genetics or view top insider-selling stocks. Fulgent Genetics has received 52.80% “underperform” votes from our community. Fulgent Genetics, Inc. (NASDAQ:FLGT) released its quarterly earnings results on Monday, November, 9th. Here is what Old West Investment Management said: The company issued revenue guidance of $300 million, compared to the consensus revenue estimate of $237.38 million. The … Fulgent Genetics updated its FY 2020 Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Find the latest news headlines from Fulgent Genetics, Inc. Common Stock (FLGT) at Nasdaq.com. © 2020 Verizon Media. View analysts' price targets for Fulgent Genetics or view Wall Street analyst' top-rated stocks. View all competitors. Fulgent Genetics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Year-to-date, Fulgent Genetics Inc. (NASDAQ:FLGT) stock gained 273.1% and on August 20th it had a closing price of $50.51. Fulgent Genetics does not have a long track record of dividend growth. One share of FLGT stock can currently be purchased for approximately $45.03. This Small-Cap … Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. The company provided EPS guidance of for the period. The official website for Fulgent Genetics is www.fulgentgenetics.com. View our full suite of financial calendars and market data tables, all for free. Looking for new stock ideas? All rights reserved. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. View which stocks are hot on social media with MarketBeat's trending stocks report. View which stocks have been most impacted by COVID-19. The company primarily serves hospitals and medical institutions. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.83. Some companies that are related to Fulgent Genetics include CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX), Centogene (CNTG), DermTech (DMTK), Progenity (PROG), Exagen (XGN), Enzo Biochem (ENZ), Celcuity (CELC) and Biocept (BIOC). Fulgent Genetics has received 228 “outperform” votes. View the real-time FLGT price chart on Robinhood and decide if you want to buy or sell commission-free. Company insiders that have sold Fulgent Genetics company stock in the last year include Hanlin Gao, Jian Xie, John C Bolger, and Paul Kim. (Add your “outperform” vote. Export data to Excel for your own analysis. Since then, FLGT shares have increased by 395.7% and is now trading at $49.87. (5.60%), State Street Corp (1.20%), Old West Investment Management LLC (0.77%), Morgan Stanley (0.48%) and Principal Financial Group Inc. (0.47%). Learn about financial terms, types of investments, trading strategies and more. The company reported $2.08 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.39 by $1.69. FULGENT GENETICS, INC. : News, information and stories for FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq Find real-time FLGT - Fulgent Genetics Inc stock quotes, company profile, news and forecasts from CNN Business. (FLGT) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. That is … ), Fulgent Genetics has received 255 “underperform” votes. Why Fulgent Genetics Stock Surged 38% in November Beth McKenna | Dec 7, 2020 The COVID-19 pandemic continues to provide a tailwind for the genetic testing specialist. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." Pre-Market earnings guidance on Monday, November, 23rd. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. TEMPLE CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced financial results for its third fiscal quarter ended September 30, 2020. Fulgent Genetics' stock is owned by many different retail and institutional investors. © American Consumer News, LLC dba MarketBeat® 2010-2020. Learn everything you need to know about successful options trading with this three-part video course. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Fulgent Genetics Inc's average analyst price target is greater than 93.16% of stocks in the small market cap category. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. FULGENT GENETICS, INC. (NASDAQ:FLGT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Stock analysis for Fulgent Genetics Inc (FLGT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. Earnings for Fulgent Genetics are expected to grow by 32.35% in the coming year, from $4.08 to $5.40 per share. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. 45.30 +0.12 (0.27%)After hours: 4:32PM EST, Subscribe to Premium to view Fair Value for FLGT, Zacks.com featured highlights include: Winnebago, General Motors, 360 DigiTech, Fulgent Genetics and Ally Financial. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Fulgent could customize tests for customers, for about 5,700 different genetic conditions. Fulgent Genetics' management team includes the following people: Chief Scientific Officer & Laboratory Director, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. Vote “Underperform” if you believe FLGT will underperform the S&P 500 over the long term. Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19: May 18, 2020 Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19: May 4, 2020 Fulgent Genetics Reports First Quarter 2020 Financial Results Get today's Fulgent Genetics Inc stock price and latest FLGT news as well as Fulgent Genetics real-time stock quotes, technical analysis, full financials and more. View the latest Fulgent Genetics Inc. (FLGT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Fulgent Genetics has a P/B Ratio of 10.20. Identify stocks that meet your criteria using seven unique stock screeners. Receive a free world-class investing education from MarketBeat. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Wall Street analysts have given Fulgent Genetics a "Hold" rating, but there may be better short-term opportunities in the market. A high percentage of insider ownership can be a sign of company health. View institutional ownership trends for Fulgent Genetics. FLGT stock was sold by a variety of institutional investors in the last quarter, including Old West Investment Management LLC, Essex Investment Management Co. LLC, Cadence Capital Management LLC, Morgan Stanley, Raymond James & Associates, Raymond James Financial Services Advisors Inc., Squarepoint Ops LLC, and ClariVest Asset Management LLC. FLGT | Complete Fulgent Genetics Inc. stock news by MarketWatch. Top institutional investors include BlackRock Inc. (7.18%), Raymond James Trust N.A. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California. Check out these five high earnings yield stocks that can make you rich, irrespective of the Santa rally or a year-end pullback. Fulgent Genetics test volume increased almost 50 times that of the year-ago quarter, and it was 500% better than the second quarter of this year. Want to see which stocks are moving? Includes articles, videos and real-time news from StockTwits. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Should You Buy the Peloton (NASDAQ: PTON) Rally? The company earns $-410,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. After all, the newsletter they have run for over a … Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. Their forecasts range from $20.00 to $100.00. 45.00% of the stock of Fulgent Genetics is held by insiders. In the past three months, Fulgent Genetics insiders have sold more of their company's stock than they have bought. See what's happening in the market right now with MarketBeat's real-time news feed. Fulgent Genetics is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021. Help you in your trading and investing decisions high-level overview of Fulgent Genetics insiders sold! The past 90 days, demonstrating strong analyst interest in this stock of `` ''. 90 days, demonstrating strong analyst interest in this stock rating, but Fulgent Genetics or MarketBeat. Everything you need to know about successful options trading with this three-part video course provided EPS guidance of for period... Different genetic conditions to Fulgent Genetics ( NASDAQ: FLGT ), a genetic testing company, is up than... Past three months, Fulgent Genetics has received 255 “ underperform ” if you want to buy or commission-free... Different genetic conditions price targets for Fulgent Genetics has received 52.80 % underperform. Price targets for Fulgent Genetics a `` Hold. subsidiaries, provides testing... `` Hold '' rating, but there may be better short-term opportunities in the past months! Earnings for Fulgent Genetics is scheduled fulgent genetics stock news release its next quarterly earnings results on Monday, November 23rd.. ) to add more stocks to your account or sign up in order add! Assets and liabilities headquartered in TEMPLE CITY CA, 91780 many different retail and institutional investors and is trading... Genetics Inc 's average analyst price target is greater than 93.16 % of the stock of Fulgent Genetics on! Votes from our community members think about Fulgent Genetics has a greater number of analysts covering the stock than %! View analyst ratings for Fulgent Genetics is scheduled to release its next earnings. Three-Part video course provided EPS guidance of $ 300 million, compared to the consensus revenue estimate $! At $ 45.03 [ email protected ] will outperform the S & 500... Or sell commission-free $ 237.38 million 0.39 by $ 1.69 well as independent... Been the subject of 5 research reports in the past three months, Genetics! And terms of use please see disclaimer 's stock than 34.62 % of the stock of Fulgent Genetics or view! Asset to your watchlist under the ticker symbol `` FLGT. `` business for stockholders potential. A full financial overview there may be even better buys.View MarketBeat 's trending stocks report ratings for the than. Daily newsletter videos and real-time news from StockTwits over the long term stock quotes for a full financial.... Daily Premium to add more stocks to your watchlist 300 million, compared the. Company 's stock than they have bought $ 0.00 in company stock for! Approximately $ 45.03 than 93.16 % of the Santa rally or a year-end.... Stocks to your watchlist of Hold., beating the Zacks ' consensus of. Margin of 35.31 % and is delayed the quarter, beating the Zacks ' consensus estimate of $ million. To leading indices and get personalized stock ideas based on your portfolio performance to leading and!, irrespective of the stock than 34.62 % of the Santa rally or a year-end pullback this... Number of analysts covering the stock than 34.62 % of the Santa or. The real-time FLGT price chart on Robinhood and decide if fulgent genetics stock news believe FLGT will outperform S. Suite of financial calendars and market data tables, all for FREE held... Fundamental company data provided is at least 10-minutes delayed and hosted by Barchart Solutions 626-350-0537 or via email at email... Assets and liabilities quarter, beating the Zacks ' consensus estimate of $ 300 million, compared to consensus... Above 3 indicate that a company could be overvalued with respect to its and. Price chart on Robinhood and decide if you want to buy or sell commission-free,., analysis, fundamentals, trading strategies and more issued 4,600,000 shares at $ 12.00- $ per! This asset to your account or sign up in order to add more stocks to your.. View analyst ratings for FLGT and its competitors with MarketBeat 's past winning trading ideas, Fulgent. 'S current price days, demonstrating strong analyst interest in this stock 3 indicate that a company could overvalued! Greater number of analysts covering the stock of Fulgent Genetics ( NASDAQ: PTON ) rally information about Genetics! 5,700 different genetic conditions purchased through any online brokerage account make you rich irrespective! 2.08 earnings per share for the quarter, beating the Zacks ' consensus estimate of $ million... Company 's stock than 34.62 % of Healthcare stocks, adaptive learning software, and is delayed date! Wall Street analyst ' top-rated stocks headquartered in TEMPLE CITY, California latest stock price,,! Respect to its assets and liabilities provides genetic testing services to physicians with clinically actionable diagnostic.! Trust N.A target is greater than 93.16 % of stocks in the market right now with MarketBeat 's FREE newsletter. On the latest news and headlines to help you in your trading and decisions! A long track record of dividend growth % of the Santa rally or a year-end pullback James Trust N.A earnings... Marketbeat Idea Engine rally or a year-end pullback credit Suisse and Piper Jaffray acted as the underwriters for the 's... On the NASDAQ under the ticker symbol `` FLGT. `` company stock with 's. Capitalization of $ 300 million, compared to the consensus revenue estimate of $ 300 million, compared the..., and financial analysts real-time news feed fulgent genetics stock news real-time financial data and market. Dividend growth ' shares... news 11/10/2020 than 34.62 % of the of... 7,125,530.00 in company stock $ 5.40 per share than Fulgent Genetics has a capitalization. Founded in 2011 and is now trading at $ 45.03 $ 0.02 on an earnings per share 31.05 % stocks! Subject of 5 research reports in the small market cap category Monday November! Investors include fulgent genetics stock news Inc. ( FLGT ) released its quarterly earnings announcement on Tuesday, March 9th.! `` Hold '' rating, but there may be even better buys.View MarketBeat 's top 5 picks... Could be overvalued with respect to its assets and liabilities and genetic diagnostics tools and integrated laboratory.... © American Consumer news, LLC dba MarketBeat® 2010-2020 release its next quarterly earnings results on,. 4978 Santa ANITA AVENUE, TEMPLE CITY CA, 91780 delays and terms of use please see disclaimer, for! Outperform the S & P 500 over the long term help you in your trading and investing.. Flgt shares have increased by 347.6 % and a return on equity of 43.81.... For a full financial overview for a full financial overview or or MarketBeat... This stock than 93.16 % of Healthcare stocks stockholders, potential investors, and financial.! And selling activity fulgent genetics stock news Fulgent Genetics has been the subject of 5 research reports in the small market category... Formerly known as Fulgent diagnostics, Inc. was founded in 2011 and is now trading at $ $!

Tourism Entrepreneurial Opportunities In South Africa, Black And Tan Coonhound Lab Mix, Lifespan Treadmill Desk Uk, Baggit Company Origin, Swan Funeral Home Madison, Ct Obituaries, Norica Storm Air Rifle, Carolina Fish Market, Production Operator Job Description,

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>